Company
Headquarters: Paris, France
CEO: Ms. Sophie Boissard
€685.7 Million
EUR as of Jan. 1, 2025
US$713.5 Million
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Korian provides integrated health and care services for the elderly in France, Germany, Belgium, Italy, Spain, and the Netherlands. The company operates long-term care nursing homes, specialized clinics, and assisted living and shared housing facilities for seniors, as well as offers homecare and hospital-at-home services. As of December 31, 2020, it operated 1,000 facilities with 88,651 beds. Korian has a partnership with Aedifica to invests in new property development projects in the Netherlands. The company was formerly known as Korian-Medica S.A. and changed its name to Korian in July 2015. Korian was founded in 2001 and is headquartered in Paris, France.
Korian has the following listings and related stock indices.
Stock: FSX: KO2 wb_incandescent
Stock: Euronext: KORI wb_incandescent